Literature DB >> 24736433

p53 modulates Hsp90 ATPase activity and regulates aryl hydrocarbon receptor signaling.

Amit Kochhar1, Levy Kopelovich2, Erika Sue2, Joseph B Guttenplan1, Brittney-Shea Herbert2, Andrew J Dannenberg2, Kotha Subbaramaiah3.   

Abstract

The aryl hydrocarbon receptor (AhR), a client protein of heat shock protein 90 (Hsp90), is a ligand-activated transcription factor that plays a role in polycyclic aromatic hydrocarbon (PAH)-induced carcinogenesis. Tobacco smoke activates AhR signaling leading to increased transcription of CYP1A1 and CYP1B1, which encode proteins that convert PAHs to mutagens. Recently, p53 was found to regulate Hsp90 ATPase activity via effects on activator of Hsp90 ATPase (Aha1). It is possible, therefore, that AhR-dependent expression of CYP1A1 and CYP1B1 might be affected by p53 status. The main objective of this study was to determine whether p53 modulated AhR-dependent gene expression and PAH metabolism. Here, we show that silencing p53 led to elevated Aha1 levels, increased Hsp90 ATPase activity, and enhanced CYP1A1 and CYP1B1 expression. Overexpression of wild-type p53 suppressed levels of CYP1A1 and CYP1B1. The significance of Aha1 in mediating these p53-dependent effects was determined. Silencing of Aha1 led to reduced Hsp90 ATPase activity and downregulation of CYP1A1 and CYP1B1. In contrast, overexpressing Aha1 was associated with increased Hsp90 ATPase activity and elevated levels of CYP1A1 and CYP1B1. Using p53 heterozygous mutant epithelial cells from patients with Li-Fraumeni syndrome, we show that monoallelic mutation of p53 was associated with elevated levels of CYP1A1 and CYP1B1 under both basal conditions and following treatment with benzo[a]pyrene. Treatment with CP-31398, a p53 rescue compound, suppressed benzo[a]pyrene-mediated induction of CYP1A1 and CYP1B1 and the formation of DNA adducts. Collectively, our results suggest that p53 affects AhR-dependent gene expression, PAH metabolism, and possibly carcinogenesis. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24736433      PMCID: PMC4074578          DOI: 10.1158/1940-6207.CAPR-14-0051

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  50 in total

Review 1.  Impact of cellular metabolism on the biological effects of benzo[a]pyrene and related hydrocarbons.

Authors:  K P Miller; K S Ramos
Journal:  Drug Metab Rev       Date:  2001-02       Impact factor: 4.518

2.  Association of the dioxin receptor with the Mr 90,000 heat shock protein: a structural kinship with the glucocorticoid receptor.

Authors:  M Denis; S Cuthill; A C Wikström; L Poellinger; J A Gustafsson
Journal:  Biochem Biophys Res Commun       Date:  1988-09-15       Impact factor: 3.575

3.  The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs.

Authors:  J A Ali; A P Jackson; A J Howells; A Maxwell
Journal:  Biochemistry       Date:  1993-03-16       Impact factor: 3.162

4.  Activation and control of p53 tetramerization in individual living cells.

Authors:  Giorgio Gaglia; Yinghua Guan; Jagesh V Shah; Galit Lahav
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-04       Impact factor: 11.205

5.  An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.

Authors:  Christiane A Opitz; Ulrike M Litzenburger; Felix Sahm; Martina Ott; Isabel Tritschler; Saskia Trump; Theresa Schumacher; Leonie Jestaedt; Dieter Schrenk; Michael Weller; Manfred Jugold; Gilles J Guillemin; Christine L Miller; Christian Lutz; Bernhard Radlwimmer; Irina Lehmann; Andreas von Deimling; Wolfgang Wick; Michael Platten
Journal:  Nature       Date:  2011-10-05       Impact factor: 49.962

6.  The mutant p53-conformation modifying drug, CP-31398, can induce apoptosis of human cancer cells and can stabilize wild-type p53 protein.

Authors:  Rishu Takimoto; Wenge Wang; David T Dicker; Farzan Rastinejad; Joseph Lyssikatos; Wafik S el-Deiry
Journal:  Cancer Biol Ther       Date:  2002 Jan-Feb       Impact factor: 4.742

7.  Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53.

Authors:  M F Denissenko; A Pao; M Tang; G P Pfeifer
Journal:  Science       Date:  1996-10-18       Impact factor: 47.728

8.  Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1.

Authors:  J H Kim; K H Stansbury; N J Walker; M A Trush; P T Strickland; T R Sutter
Journal:  Carcinogenesis       Date:  1998-10       Impact factor: 4.944

9.  Lung cancer risk in germline p53 mutation carriers: association between an inherited cancer predisposition, cigarette smoking, and cancer risk.

Authors:  Shih-Jen Hwang; Li Shu-Chung Cheng; Guillermina Lozano; Christopher I Amos; Xiangjun Gu; Louise C Strong
Journal:  Hum Genet       Date:  2003-06-11       Impact factor: 4.132

10.  A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.

Authors:  Brittney-Shea Herbert; Rebecca A Chanoux; Yunlong Liu; Peter H Baenziger; Chirayu P Goswami; Jeanette N McClintick; Howard J Edenberg; Robert E Pennington; Steven M Lipkin; Levy Kopelovich
Journal:  Oncotarget       Date:  2010-10
View more
  12 in total

Review 1.  HSP90AB1: Helping the good and the bad.

Authors:  Michael Haase; Guido Fitze
Journal:  Gene       Date:  2015-09-07       Impact factor: 3.688

2.  Retraction: p53 Modulates Hsp90 ATPase Activity and Regulates Aryl Hydrocarbon Receptor Signaling.

Authors:  Amit Kochhar; Levy Kopelovich; Erika Sue; Joseph B Guttenplan; Brittney-Shea Herbert; Andrew J Dannenberg; Kotha Subbaramaiah
Journal:  Cancer Prev Res (Phila)       Date:  2022-06-02

Review 3.  The Potential Application and Promising Role of Targeted Therapy in Pulmonary Arterial Hypertension.

Authors:  Meng-Chien Willie Hsieh; Wei-Ting Wang; Jwu-Lai Yeh; Chuang-Yu Lin; Yur-Ren Kuo; Su-Shin Lee; Ming-Feng Hou; Yi-Chia Wu
Journal:  Biomedicines       Date:  2022-06-15

4.  Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells.

Authors:  Kotha Subbaramaiah; Kristy A Brown; Heba Zahid; Gabriel Balmus; Robert S Weiss; Brittney-Shea Herbert; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

5.  Effects of Black Raspberry Extract and Protocatechuic Acid on Carcinogen-DNA Adducts and Mutagenesis, and Oxidative Stress in Rat and Human Oral Cells.

Authors:  Joseph B Guttenplan; Kun-Ming Chen; Yuan-Wan Sun; Wieslawa Kosinska; Ying Zhou; Seungjin Agatha Kim; Youngjae Sung; Krishne Gowda; Shantu Amin; Gary D Stoner; Karam El-Bayoumy
Journal:  Cancer Prev Res (Phila)       Date:  2016-06-07

Review 6.  Regulation of the Tumor-Suppressor Function of the Class III Phosphatidylinositol 3-Kinase Complex by Ubiquitin and SUMO.

Authors:  Christina Reidick; Fouzi El Magraoui; Helmut E Meyer; Harald Stenmark; Harald W Platta
Journal:  Cancers (Basel)       Date:  2014-12-23       Impact factor: 6.639

Review 7.  Regulation of the Tumor-Suppressor BECLIN 1 by Distinct Ubiquitination Cascades.

Authors:  Fahd Boutouja; Rebecca Brinkmeier; Thomas Mastalski; Fouzi El Magraoui; Harald W Platta
Journal:  Int J Mol Sci       Date:  2017-11-27       Impact factor: 5.923

8.  2,3,7,8‑tetrachlorodibenzo‑p‑dioxin suppresses the growth of human colorectal cancer cells in vitro: Implication of the aryl hydrocarbon receptor signaling.

Authors:  Masayoshi Yamaguchi; Oliver Hankinson
Journal:  Int J Oncol       Date:  2019-01-30       Impact factor: 5.650

9.  Targeting cancer stem cells with p53 modulators.

Authors:  Zhan Zhang; Ling Liu; Roberto Gomez-Casal; Xinhui Wang; Ryo Hayashi; Ettore Appella; Levy Kopelovich; Albert B DeLeo
Journal:  Oncotarget       Date:  2016-07-19

10.  E-cigarette Aerosol Condensate Enhances Metabolism of Benzo(a)pyrene to Genotoxic Products, and Induces CYP1A1 and CYP1B1, Likely by Activation of the Aryl Hydrocarbon Receptor.

Authors:  Yuan-Wan Sun; Wieslawa Kosinska; Joseph B Guttenplan
Journal:  Int J Environ Res Public Health       Date:  2019-07-11       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.